3[4]Louvet C,Andre T,Tigaud JM,et al.Phase study of oxaliplatin,fluorouracil,and folinic acid in locally advanced or metastatic gastric cancer patients[J].J Clin Oncol,2002,20(23):4543～4548.
4[5]Grolleau F,Gamelin L,Boisdron-Celle M,et al.A possible explanation for a neurotoxic effect of the anticancer agent oxaliplatin on neuronal voltage-gated sodium channels[J].J Neurophysiol,2001,85(5):2293～2297.
5Machover D,Diaz Rubil E,de Gramont A,et al,Two consecutive phase Ⅱ studies of oxaliplatin for treat ment of patients with adnanced colorectal carcinoma who were resistsnt to previous treat ment with fluoropyrimidines[J].Ann Oncol,1996,7(1):95-98.
6王少华,杜冠华.肿瘤合理用药[M].北京:人民卫生出版社,2004.239-240.
7Fischel JL,Rostagno P,Forfmento P,et al.Ternary combination of irinotecan,fluorouracil-Folinic acid and oxaliplatin:Results on human colon cancer cell lines [ J ].Br J Cancer,2001,84(4):579.
8Moiseyenko VM,Ajani JA,Tjulandin SA,et al.Final results of a randomized controlled phase Ⅲ trial (TAX 325) comparing docetaxel (T) combined with cisplatin (C) and 5-fluorouracil (F)to CF in patients (pts) with metastatic gastric adenocarcinoma (MGC)[ J ].J Clin Onc,Proc Am Soc Clin Oncol,2005,23:Abstract 4002.
9Al-Batran S,Hartmann J,Probst S,et al.A randomized phase Ⅲ trial in patients with advanced adenocarcinoma of the stomach receiving first-line chemotherapy with fluorouracil,leucovorin and oxaliplatin (FLO) versus fluorouracil,leucovorin and cisplatin (FLP)[J].J Clin Onc,Proc Am Soc Clin Oncol,2006,24:Abstract 4016.
10Bugat R.Irinotecan in the treatment of gastric cancer[J].Ann Oncol,2003,14(Suppl 2):37 -40.
5Gamelin E, Gamelin L, Bossi L, et al. Clinical aspects and molecular basis of oxaliplatin neurotoxicity: current management and development of preventive measures [ J ]. Semin Oncol, 2002, 9 (5 suppl 15) : 21 - 33.
6Li Y, Yu Z, Tan L, et al. Oral glutanune ameliorates chemotherapy - induced changes of imestinal permeability and does not interfere with the antitumor effect of chemotherapy in patients with breast cancer: a prospective randomizedtrial [J]. Tumori, 2008, 94 (4): 624 - 626.
7Cerchietti LC, Navigante AH, Lutteral MA, et al. Double - blinded, placebo - controlled trial on intravenous L - alanyl - L - glutamine in the incidence of oral mucositis following chemoradiotherapy in patients with head- and - neck cancer [ J ]. Int J Radiat Oncol Biol Phys, 2006, 65 (5): 1330-1337.
8Oguz M, Kerem M, Bedirli A, et al. L - alanin - L - glutamine supplementation improves the outcome after colorectal surgery for cancer [ J ]. Colorectal Dis, 2007, 9 ( 6 ) : 515 -520.
9Gwag BJ, Sessler FM, Robine V, et al. Endogenous glutamate levels regulate nerve growth factor mRNA expression in the rat dentate gyrus [ J]. Mol Cells, 1997, 7(3) : 425 - 430.
10Cavaletti G, Petruccioli MG, Marmiroli P, et al. Circulating nerve growth factor level changes during oxaliplatin treatment - induced neurotoxicity in the rat [ J]. Anticancer Res, 2002, 22 (6C): 4199-4204.
